Shengying Qian
State Key Laboratory Of Drug Research
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Alcohol consumption potentiates second-hit events in HBV-induced hepatocellular carcinoma.
Journal: Journal of hepatology
Published: September 18, 2025
ANXA1-FPR1 signaling in myeloid cells drives MASH by elevating S100A4/A11.
Journal: JHEP reports : innovation in hepatology
Published: September 05, 2025
Hepatic IκBζ promotes alcohol-associated liver disease and acute hepatitis by enhancing CXCL1-Mediated neutrophil infiltration.
Journal: Free radical biology & medicine
Published: April 09, 2025
Aldehyde Dehydrogenase 2 Deficiency Impairs Liver Progenitor Cell Proliferation in Alcohol-Fed Mice.
Aldehyde Dehydrogenase 2 Deficiency Impairs Liver Progenitor Cell Proliferation in Alcohol-Fed Mice.
Journal: The American journal of pathology
Published: April 01, 2025
Immunopathogenic mechanisms and immunoregulatory therapies in MASLD.
Journal: Cellular & molecular immunology
Published: March 31, 2025
Hepatic microRNA-320 restrains ferroptosis to mitigate acute-on-chronic alcohol-induced liver injury.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: November 04, 2024
Downregulation of ubiquitous microRNA-320 in hepatocytes triggers RFX1-mediated FGF1 suppression to accelerate MASH progression.
Journal: Acta pharmaceutica Sinica. B
Published: June 18, 2024
Inflammation in Steatotic Liver Diseases: Pathogenesis and Therapeutic Targets.
Journal: Seminars in liver disease
Published: June 05, 2024
A novel experimental mouse model of diabetic nonalcoholic steatohepatitis: A critical role for acid-sensitive Ion Channel 1a.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 02, 2024
Showing 1-10 of 10
Last Updated: 09/26/2026